fda warning glutathione injectable skin lightening highlights concerns with using dietary ingredient to compound sterile injectables ​FDA: No IV glutathione product

Physical illness and schizophrenia: a review of the literature

1984;140(2):282-286 Benseor IM, Calich AL, Brunoni AR, et al

Dilokthornsakul W., Dhippayom T., Dilokthornsakul P

And what they do in that environment is the media will list any recall, any mistake a compounding pharmacy makes, but sweep under the rug that big pharmaceutical companies like Eli Lilly and Pfizer have moved most of their manufacturing overseas, where the FDA has to submit before they can come do an inspection, and has to give them two months notice because they're coming into a foreign country and they've got to get visas and approvals and all these things to come inspect those facilities

switching PO to IV therapy is an option